Biotechnology News

December 12, 2012

TAINAN, Taiwan--(BUSINESS WIRE)--The Society of Genetics, Genomics and Computational Biology had officially set up an education center at National Cheng Kung University (NCKU), southern Taiwan, to facilitate genetics and computational biology...

December 11, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG), announced results from several studies evaluating combination treatment with REVLIMID® (lenalidomide) and antibody therapy in...

December 11, 2012

STAMFORD, Conn.--(BUSINESS WIRE)--Stamford Hospital is the first and only hospital in Conn. to use Xenex's innovative room disinfection technology to further increase patient safety by eliminating superbugs which cause infections.

December 11, 2012

HOUSTON--(BUSINESS WIRE)--Medical Metrics selected as imaging core lab by five leading orthopedic sponsors to support multiple cross-sectional, post-market, FDA clinical trials of MoM hip implants.

December 11, 2012

TWINSBURG, Ohio--(BUSINESS WIRE)--Inc. Magazine recognizes EnvisionRxOptions for leading the way in creating American jobs

December 11, 2012

DENMEAD, England--(BUSINESS WIRE)--Microsulis Medical Ltd, the medical device company specialising in minimally invasive, microwave ablation technology for the coagulation of soft tissue, has received FDA clearance for its upgraded Accu2i pMTA...

December 11, 2012

LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT announces that it has begun a U.S. clinical trial to evaluate the Spectra Optia system’s new Red Blood Cell Exchange (RBCX) Protocol in patients with sickle cell disease.

December 11, 2012

BUC, France--(BUSINESS WIRE)--GE Healthcare announces the first global installation in France of the Discovery IGS 730 system for hybrid Operating Rooms and imaging departments. It will allow performing complex minimally-invasive endovascular and...

December 11, 2012

VANCOUVER, British Columbia--(BUSINESS WIRE)--M*Modal Canada, a leading provider of clinical documentation and speech understanding solutions, today announced that Providence Health Care (PHC), leader of consolidated Health Information Management...

December 11, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--New study finds that drug developers save time on Phase I trials when using fewer sites to recruit patients.

December 11, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--23andMe has raised $50 million in a new financing round. This investment will support our growth goal of one million actively engaged customers by the end of 2013.

December 11, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is hosting an educational webinar entitled Transient Transfection of Biologically Relevant Cells: CEVEC CAP-T™ Technology...

December 11, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--More than three-quarters (77%) of surveyed pharmaceutical companies have created dedicated portfolio management teams, according to a study by Cutting Edge Information.

December 11, 2012

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter has announced that it has now been approved as a “Known Consignor” by the German Federal Aviation Office.

December 11, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Collaborators present data supporting use of Sequenta's LymphoSIGHT method for acute lymphoblastic leukemia.

December 11, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Diffusion Pharmaceuticals LLC announced today that trans sodium crocetinate (TSC), the company’s lead drug candidate, has been granted an Orphan Drug designation by the U.S. Food and Drug Administration (FDA...

December 11, 2012

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Diagnostics company SynapDx Corporation secures $6 million to advance efforts in early detection of autism and announces that former Genzyme EVP Robert Carpenter joins the board.

December 11, 2012

BOSTON and GENEVA--(BUSINESS WIRE)--Patient-Driven eData solutions provider PHT Corporation patents "Time Travel" technology for more efficient testing and clinician and patient eDiary training for clinical research programs.

December 11, 2012

NEW YORK--(BUSINESS WIRE)--BRISTOL-MYERS SQUIBB FOUNDATION AWARDS MENTAL HEALTH GRANTS OF NEARLY $3 MILLION TO SUPPORT RETURNING VETERANS

December 11, 2012

NEW YORK & PETACH TIKVA, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, is proud to announce that its positive Phase I/II ALS clinical...

December 11, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today announced data from its phase III, multi-center, randomized (2:1), open-label study (MM-003, n=455) of pomalidomide plus...

December 11, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced results from the “EMERGE” study (MCL-001), a phase II, multi-center, single-arm trial evaluating REVLIMID® (lenalidomide) in patients with previously...

December 11, 2012

MALVERN, Pa. & ST. LOUIS--(BUSINESS WIRE)--GALERA THERAPEUTICS RAISES $11 MILLION IN SERIES A FINANCING to Support Clinical Development of Therapeutics for Fibrosis and Cancer;
Names Mel Sorensen, M.D. New President and CEO

December 11, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the company and its collaborators...

December 11, 2012

ATLANTA & CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced twelve-month follow-up data from the pivotal PACE trial of ponatinib, its investigational BCR-ABL inhibitor, in heavily pretreated...

December 11, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer launches a new range of assay kits utilizing AlphaLISA® technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs.

December 11, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced results from an analysis of post-progression outcomes in MM-015, a phase III study of continuous REVLIMID® (lenalidomide) plus melphalan and...

December 11, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex announced positive results from Phase 1 CDX-301 study. CDX-301 was well-tolerated and safely and effectively mobilized hematopoietic cell populations in healthy volunteers.

December 11, 2012

CHICAGO--(BUSINESS WIRE)--Durata Therapeutics announced preliminary, top-line results for its DISCOVER 1 Phase 3 study of dalbavancin for the treatment of ABSSSI. Conference Call/Webcast today at 9am ET to discuss results.

December 11, 2012

AMITYVILLE, N.Y.--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is scheduled to make an investor presentation at the Oppenheimer 23rd Annual Healthcare Conference Thursday, December 13, 2012, at 10:00 a.m....

December 11, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals announced new data on previously untreated elderly patients with acute myeloid leukemia (AML) and multiple-risk factors treated with CPX-351 (cytarabine:daunorubicin)

December 11, 2012

TORONTO--(BUSINESS WIRE)--The US laser, light and energy device market will grow at a strong pace through 2017, as multiapplication systems and handpieces are increasingly adopted.

December 11, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Novella Clinical, a full service clinical research organization (CRO), today announced the addition of three Directors of Client Service: Pamela Kennedy, RN; Fabio Mariano & Matthew O’Rourke.

December 11, 2012

AURORA, Colo.--(BUSINESS WIRE)--Altria Ventures invests $2M in Sharklet Technologies to advance world's first micro-texture that inhibits bacterial survival.

December 11, 2012

DERIO, Spain--(BUSINESS WIRE)--Oncomatrix, a biopharmaceutical company from the Basque country, Spain, develops personalized treatments for invasive tumors. Oncomatrix has signed an agreement with the University of Stuttgart to develop new drugs...

December 11, 2012

ATLANTA--(BUSINESS WIRE)--Astellas Pharma Inc. (Tokyo: 4503, Astellas) and Ambit Biosciences Corporation today announced the results from a completed phase II study with the investigational FLT3 inhibitor, quizartinib (AC220), as an oral...

December 11, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals announced that its Board of Directors has approved the payment of a year-end special dividend of $0.15 to holders of common stock of record at close of business on 12/20/12.

December 11, 2012

JERUSALEM--(BUSINESS WIRE)--Canine monocytic ehrlichiosis (CME) is a major, potentially fatal, tick-borne dog disease prevalent worldwide. No commercial vaccine for the disease is currently available and tick control is the main preventive...

December 11, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Moximed has started a US clinical study with the KineSpring System for knee osteoarthritis.

December 11, 2012

ATLANTA--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today highlighted clinical data from two antibody-drug conjugate (ADC) programs in development by Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) that utilize...

December 11, 2012

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--MANTRA is a new European Community research project to enrich multilingual terminologies which are used in text mining in the biomedical domain.

December 11, 2012

BETHESDA, Md. & TOKYO--(BUSINESS WIRE)--Sucampo Receives $15 Million Milestone Payment from Abbott on First Sale of AMITIZA® (lubiprostone) in Japan

December 11, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Targeted KO disease model using meganuclease genome engineering technology

December 11, 2012

NEW YORK & BARCELONA, Spain--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE:FRX) and Almirall, S.A. (ALM:MC) announced today that Tudorza™ Pressair™ (aclidinium bromide inhalation powder) 400mcg is now available in pharmacies throughout the...

December 11, 2012

ZURICH & BARCELONA, Spain--(BUSINESS WIRE)--The seventh annual BIO-Europe Spring® international partnering conference will be held in Barcelona, Spain March 11–13, 2013 at the CCIB Convention Centre Barcelona. The event is expected to draw 2,...

December 10, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced that results from a study evaluating the combination of REVLIMID (lenalidomide) plus VIDAZA (azacitidine) in patients 60 years or older with untreated...

December 10, 2012

WESTLAKE, Ohio--(BUSINESS WIRE)--Q-Lab, the worldwide leader in accelerated weathering test equipment and outdoor exposure test services, is pleased to announce the launch of a new Japanese language website at...

December 10, 2012

ATLANTA--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today announced results from a phase I clinical trial of ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed advanced stage Hodgkin...

December 10, 2012

ATLANTA--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that results from two ongoing investigator-sponsored phase II clinical trials of ADCETRIS (brentuximab vedotin) in patients with relapsed cutaneous T-cell lymphoma (...